<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 

IPO-2

IPO OF THE YEAR

 
This award recognises a company that has successfully completed a significant, impactful or transformational IPO on any international exchange.
 
It is open to European life science companies only.

Qualifying criteria

- Must be a public company
- Must have raised the funds in the period between 1 September 2018 to 1 September 2019
- Must be a company with a European headquarters
- Raise must be an IPO NOT a secondary placement or follow-on 

Judges will be paying particular attention to:

- Amount of funds raised
- Process / speed / allocation fulfilment of securing of significant new funds
- Level / reputation of new investor(s) attracted
- Post-finance allocation / use of proceeds
- Level of value creation / value realisation from raise
 
 
SUBMIT YOUR NOMINATION